New perspectives in the management of depression. Symposium highlights from ECNP, Venice, September 1995.
D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy; D015897:Comorbidity; D003866:Depressive Disorder / Q000188:drug therapy* / Q000517:prevention & control; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D010879:Piperazines; D014230:Triazoles / Q000009:adverse effects / Q000627:therapeutic use*
D018687:Antidepressive Agents, Second-Generation; D010879:Piperazines; D014230:Triazoles; C051752:nefazodone; D007099:Imipramine